Literature DB >> 1374144

Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus.

K Kamata1, N Miyata, T Abiru, Y Kasuya.   

Abstract

To investigate the influence of diabetes mellitus on the responsiveness of the vascular smooth muscle, the effects of various vasoactive agents on the reactivity of the vascular smooth muscle from diabetic animals have been undertaken, focusing on the functional changes in the endothelium, alpha-adrenoceptors, beta-adrenoceptors, voltage-dependent Ca(2+)-channels, receptor-operated Ca(2+)-channels, phosphatidylinositol turnover and potassium channels. Among the functional changes, it is a common phenomenon that decreases in acetylcholine-induced production of cyclic GMP are due to the attenuation of release of endothelium-derived relaxing factor through an impairment of endothelium; this observation was found in both rats and rabbits with diabetes mellitus. These functional changes in diabetes may be responsible for the vascular complications such as coronary heart disease, cerebrovascular disease, and an acceleration in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374144     DOI: 10.1016/0024-3205(92)90256-o

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  Selenium restores defective beta-adrenergic receptor response of thoracic aorta in diabetic rats.

Authors:  Esma N Zeydanli; Ayca Bilginoglu; Evrim Tanriverdi; Hakan Gurdal; Belma Turan
Journal:  Mol Cell Biochem       Date:  2009-12-18       Impact factor: 3.396

2.  Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycemic clamp.

Authors:  Birgit Wilhelm; Matthias M Weber; Hans Peter Kreisselmeier; Matthias Kugler; Claudius Ries; Andreas Pfützner; Peter H Kann; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2007-07

3.  Effects of the SOD mimic nitroxide 3-carbamoyl-PROXYL on oxidative stress markers and endothelial dysfunction in streptozotocin-induced diabetic rats.

Authors:  Abdullah Haj-Yehia; Taher Nassar; Bashir Kadery; Chaim Lotan; Nael Da'as; Yosef Kleinman
Journal:  Exp Clin Cardiol       Date:  2002

4.  Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.

Authors:  Young-Eun Cho; Aninda Basu; Anzhi Dai; Michael Heldak; Ayako Makino
Journal:  Am J Physiol Cell Physiol       Date:  2013-08-28       Impact factor: 4.249

5.  Identification of the molecular basis for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes.

Authors:  J A Buczek-Thomas; T B Miller
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396

6.  Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine.

Authors:  K Kamata; M Sugiura; S Kojima; Y Kasuya
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

Review 7.  Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications.

Authors:  O Traub; R Van Bibber
Journal:  West J Med       Date:  1995-05

8.  Molecular effects of C-Peptide in microvascular blood flow regulation.

Authors:  Thomas Forst; Thomas Hach; Thomas Kunt; Matthias M Weber; Andreas Pfützner
Journal:  Rev Diabet Stud       Date:  2009-11-10

9.  Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment.

Authors:  Cimen Karasu
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

10.  High-glucose-induced endothelial cell injury is inhibited by a Peptide derived from human apolipoprotein E.

Authors:  Partha S Bhattacharjee; Tashfin S Huq; Valencia Potter; Anna Young; Ian R Davenport; Richard Graves; Tarun K Mandal; Christian Clement; Harris E McFerrin; Syed Muniruzzaman; Shubha K Ireland; James M Hill
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.